|
|
|
42
|
B001A
|
APO-CABERGOLINE 0.5MG TAB (APO) CAB
|
CABERGOLINE
|
APO-CABERGOLINE
|
8'S
|
BQ
|
27.73
|
3.47
|
TAB
|
32
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
283620
|
DOPAMINE RECEPTOR AGONIST
|
2026-04-01
|
|
|
ORAL
|
0
|
DOPAMINE RECEPTOR AGONIST
|
|
|
|
|
40
|
B001D
|
CABERGOLINE 0.5MG TAB (TMP/AHI)
|
CABERGOLINE
|
CABERGOLINE
|
4'S
|
BQ
|
30.83
|
7.71
|
TABLET
|
0
|
TAB
|
TMP
|
THE MADRAS PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283620
|
DOPAMINE RECEPTOR AGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
B001E
|
APO-CABERGOLINE 0.5MG TAB (APO) CAB (C)
|
CABERGOLINE
|
APO-CABERGOLINE
|
8'S
|
C
|
27.73
|
3.4659
|
TAB
|
32
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
283620
|
DOPAMINE RECEPTOR AGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DOPAMINE RECEPTOR AGONIST
|
|
|
|
|
42
|
B001G
|
CABERLEE 0.5MG TAB (JLP) CABERGOLINE
|
CABERGOLINE
|
CABERLEE
|
40'S
|
BQ
|
81.55
|
2.04
|
TAB
|
32
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283620
|
DOPAMINE RECEPTOR AGONIST
|
2026-04-01
|
|
|
ORAL
|
0
|
DOPAMINE RECEPTOR AGONIST
|
|